Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Optimum anti-emetic therapy for cisplatin induced emesis over repeat courses: ondansetron plus dexamethasone compared with metoclopramide, dexamethasone plus lorazepam.
Cunningham D, Dicato M, Verweij J, Crombez R, de Mulder P, du Bois A, Stewart A, Smyth J, Selby P, van Straelen D, Parideans R, McQuade B, McRae J. Cunningham D, et al. Among authors: mcquade b. Ann Oncol. 1996 Mar;7(3):277-82. doi: 10.1093/oxfordjournals.annonc.a010572. Ann Oncol. 1996. PMID: 8740792 Free article. Clinical Trial.
A multicentre, double-blind study comparing placebo, ondansetron and ondansetron plus dexamethasone for the control of cisplatin-induced delayed emesis. Ondansetron Delayed Emesis Study Group.
Olver I, Paska W, Depierre A, Seitz JF, Stewart DJ, Goedhals L, McQuade B, McRae J, Wilkinson JR. Olver I, et al. Among authors: mcquade b. Ann Oncol. 1996 Nov;7(9):945-52. doi: 10.1093/oxfordjournals.annonc.a010798. Ann Oncol. 1996. PMID: 9006746 Free article. Clinical Trial.
Ondansetron compared with granisetron in the prophylaxis of cyclophosphamide-induced emesis in out-patients: a multicentre, double-blind, double-dummy, randomised, parallel-group study. Emesis Study Group for Ondansetron and Granisetron in Breast Cancer Patients.
Stewart A, McQuade B, Cronje JD, Goedhals L, Gudgeon A, Corette L, Froger X, Tubiana-Hulin M, Laplaige P, Roberts JT, et al. Stewart A, et al. Among authors: mcquade b. Oncology. 1995 May-Jun;52(3):202-10. doi: 10.1159/000227458. Oncology. 1995. PMID: 7715904 Clinical Trial.
A double-blind, randomised, parallel group, multinational, multicentre study comparing a single dose of ondansetron 24 mg p.o. with placebo and metoclopramide 10 mg t.d.s. p.o. in the treatment of opioid-induced nausea and emesis in cancer patients.
Hardy J, Daly S, McQuade B, Albertsson M, Chimontsi-Kypriou V, Stathopoulos P, Curtis P. Hardy J, et al. Among authors: mcquade b. Support Care Cancer. 2002 Apr;10(3):231-6. doi: 10.1007/s00520-001-0332-1. Epub 2002 Feb 9. Support Care Cancer. 2002. PMID: 11904788 Clinical Trial.
Ondansetron is more effective than metoclopramide for the treatment of opioid-induced emesis in post-surgical adult patients. Ondansetron OIE Post-Surgical Study Group.
Chung F, Lane R, Spraggs C, McQuade B, Jacka M, Luttropp HH, Alahuta S, Rocherieux S, Roy M, Duvaldestin P, Curtis P. Chung F, et al. Among authors: mcquade b. Eur J Anaesthesiol. 1999 Oct;16(10):669-77. doi: 10.1046/j.1365-2346.1999.00547.x. Eur J Anaesthesiol. 1999. PMID: 10583349 Clinical Trial.
33 results